Navigation Links
GenWay Biotech's You Test You puts early cancer detection tool in the hands of consumers

San Diego-based GenWay Biotech, Inc. today announced the availability of the You Test You Cancer Assessment that allows patients to test for various types of cancer without having to visit their doctor's office, through a simple blood sample. With a 10-day turnaround time and a cost of $149, You Test You is a convenient and low cost way to periodically test for indication of cancer.

The test can be ordered online through the Web site. The patient completes an online form, which is reviewed by a You Test You doctor. Upon approval, the patient visits a local laboratory to have a blood sample taken. You Test You is an easily accessible and effective method for detecting evidence of cancer, which may lead to diagnosing and treating cancer earlier. Diagnosing cancer in the early stages can lead to successful treatment and an increased survival rate.

"The American Cancer Society has stressed the importance of early cancer detection, yet for various reasons, many Americans do not have regular checkups with their doctors", said GenWay CEO Robert Gans. "This convenient and inexpensive test will provide a valuable means for patients to be proactive and evaluate certain proteins found in the blood which are frequently associated with most cancers"

George Delgado, M.D., specialist in family medicine and voluntary associate clinical professor at UC San Diego says, "The You Test You Cancer Assessment is a great test for people who want to take charge of their health and make better health decisions."

The launch of You Test You is particularly timely, given recent recommendations from various sources setting guidelines for both breast and cervical cancer screening. The test is the first of its kind for cancer, helping patients monitor their own health. In addition to the lab-based test, a home sample collection kit will be available early this year.

According to Sergey Sikora, GenWay's Vice President of Business Development, "You Test You is a step toward putting health care into the hands of patients, many of whom do not have the time or money for expensive cancer testing. We are proud to offer a test that, with a prescription from our doctor, is widely accessible to the general consumer."


Contact: Jill Dombrauckas
858-458-0866 x119
GenWay Biotech

Related biology news :

1. GenWay Biotech obtains exclusive rights to AMDLs DR-70 cancer test in US and Canada
2. General tumor marker test now offered by GenWay clinical laboratory
3. GenWay Clinical Laboratory receives accreditation from College of American Pathologists
4. 60 second test could help early diagnosis of common brain diseases
5. Restless legs syndrome affects nearly 2 percent of US/UK children
6. Bleeding, not inflammation, is major cause of early lung infection death
7. Pig study sheds new light on the colonisation of Europe by early farmers
8. Color contrast is seen by the brain early doors
9. Extra gene copies were enough to make early humans mouths water
10. Was ability to run early mans Achilles heel?
11. New technique can be breakthrough for early cancer diagnosis
Post Your Comments:
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/9/2016)... June 9, 2016  Perkotek an innovation leader in attendance control systems is proud ... work hours, for employers to make sure the right employees are actually signing in, ... ... ... ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
Breaking Biology Technology: